Preliminary data analyzed from a Phase III Clinical Trial for anti-allergy medication PreHistin has indicated that pre-seasonal treatment clearly reduces allergy symptoms. Cobalis Corporation (Irvine, CA) conducted a randomized, double-blind, placebocontrolled study of its product, testing the safety and efficacy of PreHistin (in lozenge form) on subjects with mild to moderately severe allergic rhinitis. PreHistin's active …
No comments:
Post a Comment